BB Biotech provides further €1m for Natural Dental Implants

Existing investors High-Tech Gründerfonds (HTGF) and IBB Beteiligungsgesellschaft mbH have participated in this round. New funds will be used for commercialising the company's patented tooth replacement system.

BB Biotech was attracted by the firm's long-standing investment history in the dental implant industry. The new investor is convinced that the product will open the market to additional providers and offer a patient-friendly alternative to current methods.

HTGF and IBB also provided seed funding of $2m together with a number of business angels.

Company
Natural Dental Implants was founded in 2006 and is headquartered in Berlin with a US subsidiary in Dallas. The company developed the REPLICATE^TM Nonsurgical Tooth Replacement System. The product launch is planned for the second half of 2011.

People
Dr Matthias Dill represented HTGF and Ute Mercker managed the investment for IBB Beteiligungsgesellschaft mbH.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• DACH
• Early-stage
• Technology
• Germany
• High-Tech Gründerfonds